Towards this end, we would start the week, with expectation of extension in uptrend aiming 24500 or 24720-800. Downside marker is placed near 24250, but we will wait for slippage past 24130 to abandon the upside view.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,